EP3415127A1 — Topical glycopyrrolate formulations and a wipe containing thereof
Assigned to Rose U LLC · Expires 2018-12-19 · 7y expired
What this patent protects
The disclosure provides a topical glycopyrrolate formulation. The formulation comprises about 0.25 to about 6% w/w of a glycopyrrolate compound which is glycopyrronium bromide, and a buffering agent at an amount sufficient to maintain a pH of about 3.5 to about 6. The disclosure …
USPTO Abstract
The disclosure provides a topical glycopyrrolate formulation. The formulation comprises about 0.25 to about 6% w/w of a glycopyrrolate compound which is glycopyrronium bromide, and a buffering agent at an amount sufficient to maintain a pH of about 3.5 to about 6. The disclosure also extends to an individually packaged wipe comprising the formulation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.